WallStreetZenWallStreetZen

NASDAQ: CRBU
Caribou Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CRBU

Based on 3 analysts offering 12 month price targets for Caribou Biosciences Inc.
Min Forecast
$9.00+376.19%
Avg Forecast
$14.00+640.74%
Max Forecast
$19.00+905.29%

Should I buy or sell CRBU stock?

Based on 3 analysts offering ratings for Caribou Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRBU stock forecasts and price targets.

CRBU stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-03
lockedlocked$00.00+00.00%2024-08-07
lockedlocked$00.00+00.00%2024-05-16

1 of 1

Forecast return on equity

Is CRBU forecast to generate an efficient return?
Company
-66.26%
Industry
-759.64%
Market
50.07%
CRBU's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CRBU forecast to generate an efficient return on assets?
Company
-55.16%
Industry
26.37%
CRBU is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CRBU earnings per share forecast

What is CRBU's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$1.76
Avg 2 year Forecast
-$2.01
Avg 3 year Forecast
-$2.00

CRBU revenue forecast

What is CRBU's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$11.3M-65.88%
Avg 2 year Forecast
$13.6M-58.92%
Avg 3 year Forecast
$42.4M+28.08%
CRBU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRBU revenue growth forecast

How is CRBU forecast to perform vs Biotechnology companies and vs the US market?
Company
4.51%
Industry
35.48%
Market
9.73%
CRBU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRBU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRBU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRBU$1.89$14.00+640.74%Strong Buy
GALT$2.74$11.00+301.46%Buy
IPHA$2.14$11.50+437.38%Buy
SGMO$0.81$5.00+519.58%Buy
LCTX$0.87$5.50+532.91%Buy
View Top Biotech Stocks

Caribou Biosciences Stock Forecast FAQ

Is Caribou Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CRBU) stock is to Strong Buy CRBU stock.

Out of 3 analysts, 1 (33.33%) are recommending CRBU as a Strong Buy, 2 (66.67%) are recommending CRBU as a Buy, 0 (0%) are recommending CRBU as a Hold, 0 (0%) are recommending CRBU as a Sell, and 0 (0%) are recommending CRBU as a Strong Sell.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.

What is CRBU's earnings growth forecast for 2024-2026?

(NASDAQ: CRBU) Caribou Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.7%.

Caribou Biosciences's earnings in 2024 is -$123,438,000.On average, 6 Wall Street analysts forecast CRBU's earnings for 2024 to be -$158,740,280, with the lowest CRBU earnings forecast at -$161,749,360, and the highest CRBU earnings forecast at -$149,098,572. On average, 5 Wall Street analysts forecast CRBU's earnings for 2025 to be -$181,990,621, with the lowest CRBU earnings forecast at -$263,859,291, and the highest CRBU earnings forecast at -$152,713,083.

In 2026, CRBU is forecast to generate -$180,725,542 in earnings, with the lowest earnings forecast at -$251,208,503 and the highest earnings forecast at -$133,736,901.

What is CRBU's revenue growth forecast for 2024-2026?

(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 4.51% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.73%.

Caribou Biosciences's revenue in 2024 is $33,113,000.On average, 4 Wall Street analysts forecast CRBU's revenue for 2024 to be $1,020,828,224, with the lowest CRBU revenue forecast at $533,140,349, and the highest CRBU revenue forecast at $1,481,949,444. On average, 3 Wall Street analysts forecast CRBU's revenue for 2025 to be $1,229,204,774, with the lowest CRBU revenue forecast at $903,627,710, and the highest CRBU revenue forecast at $1,518,998,181.

In 2026, CRBU is forecast to generate $3,832,285,118 in revenue, with the lowest revenue forecast at $903,627,710 and the highest revenue forecast at $9,036,277,100.

What is CRBU's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CRBU) forecast ROA is -55.16%, which is lower than the forecast US Biotechnology industry average of 26.37%.

What is CRBU's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CRBU price target, the average CRBU price target is $14.00, with the highest CRBU stock price forecast at $19.00 and the lowest CRBU stock price forecast at $9.00.

On average, Wall Street analysts predict that Caribou Biosciences's share price could reach $14.00 by Sep 3, 2025. The average Caribou Biosciences stock price prediction forecasts a potential upside of 640.74% from the current CRBU share price of $1.89.

What is CRBU's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: CRBU) Caribou Biosciences's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that CRBU's EPS will be -$1.76 for 2024, with the lowest EPS forecast at -$1.79, and the highest EPS forecast at -$1.65. On average, analysts forecast that CRBU's EPS will be -$2.01 for 2025, with the lowest EPS forecast at -$2.92, and the highest EPS forecast at -$1.69. In 2026, CRBU's EPS is forecast to hit -$2.00 (min: -$2.78, max: -$1.48).

What is CRBU's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CRBU) forecast ROE is -66.26%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.